Cargando…
Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE
BACKGROUND: Pooled data from two large registries, Cubicin(®) Outcomes Registry and Experience (CORE; USA) and European Cubicin(®) Outcomes Registry and Experience (EU-CORE; Europe, Latin America, and Asia), were analyzed to determine the characteristics and clinical outcomes of daptomycin therapy i...
Autores principales: | Seaton, R. Andrew, Gonzalez-Ruiz, Armando, Cleveland, Kerry O., Couch, Kimberly A., Pathan, Rashidkhan, Hamed, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791778/ https://www.ncbi.nlm.nih.gov/pubmed/26976128 http://dx.doi.org/10.1186/s12941-016-0130-8 |
Ejemplares similares
-
Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE)
por: Cogo, Alberto, et al.
Publicado: (2015) -
Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE)
por: Guleri, Achyut, et al.
Publicado: (2015) -
Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database
por: Seaton, R. Andrew, et al.
Publicado: (2013) -
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2015) -
Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE)
por: Lübbert, Christoph, et al.
Publicado: (2015)